MSA receives GDP certificate following successful audit by IGJ
We are proud to announce that, following a thorough audit by the Healthcare and Youth Inspectorate (IGJ), we have received our GDP certificate (Good Distribution Practice). This certificate confirms that we meet the strict standards for the distribution of pharmaceutical products. This milestone follows our acquisition of our Farmatec license last year, marking another important step in ensuring the highest quality and safety standards within our organization.
What does the GDP certificate mean?
The GDP certificate is an important recognition within the pharmaceutical sector. It certifies that our processes and systems comply with European guidelines for the storage, distribution and handling of pharmaceutical products. These standards are essential to ensure that medicines reach pharmacies, hospitals and other healthcare institutions in a safe and controlled manner. For our organization, it is a confirmation that we handle the quality and safety of our products appropriately.
Farmatec license and further steps
Last year we also obtained our Farmatec license, which is an important requirement for distributing pharmaceutical products in the Netherlands. Following on from this, we have now taken another crucial step with the GDP certificate to further strengthen our position in the pharmaceutical supply chain. These certifications demonstrate not only our commitment to complying with laws and regulations, but also our commitment to continuous improvement and innovation within our organization.
Thanks to the team
Achieving both the Farmatec license and the GDP certificate is an accomplishment we could not have achieved without the dedication of our entire team. Together we continue to work on delivering reliable and high-quality services to our customers.
What does this mean for our customers?
For our customers, this means they can rely on a trustworthy partner that meets the highest standards within the pharmaceutical industry. We remain committed to further improving the quality of our services while ensuring the safety of medicines in the supply chain.
